Quanticate, a leading global data-focused clinical research organization (CRO), has engineered a new Remote Source Data Verification (RSDV) Platform.
The 21 CFR part 11 compliant cloud-based application allows verification of multiple clinical research sites’ source data to be completed remotely by a specialist team at a centralized location.
Throughout the COVID-19 pandemic, challenges for clinical trial sponsors and sites alike resulted in an emphasis on creating remote approaches. Quanticate built the platform to help clinical trial sponsors reduce Clinical Research Associate (CRA) travel costs and time, negate the challenges associated with movement restriction, increase data integrity and accelerate the detection of site issues.
David Underwood, founding CEO and Chairman at Quanticate said “Quanticate is an experienced niche biometric CRO supporting businesses across the pharma and biotech sectors and we constantly explore ways to enhance the services we offer our customers.“
Subscribe to our e-Newsletters
Stay up to date with the latest news, articles, and events. Plus, get special offers
from Pharmaceutical Outsourcing – all delivered right to your inbox!
Sign up now!